SCA: Sulfasalzaine for IBD(728 KB)
From 1st September 2022
Date added: 1st Aug 2022
| Drug Name | Classification | Clinical Indication | Comments |
|---|---|---|---|
| ADAFLEX®(Immediate release melatonin tablet) (NEW) | Yellow | Sleep disorders in children (see comments). Continued in adults if proven efficacy in childhood |
Doses of 10mg or less. See LLR APC melatonin guide for children for place in therapy and additional information |
| FARICIMAB (Vabysmo®) (NEW) | Red | Diabetic macular oedema |
In line with NICE TA799 |
| INCLISIRAN (Leqvio®) | Green | Treating primary hypercholesterolaemia or mixed dyslipidaemia. SECONDARY PREVENTION ONLY as per NICE TA733 |
For prescribers who feel competent to use this medication. In line with NICE TA733. For further related guidance please see the Cardiovascular Guideline |
| MELATONIN | Yellow | Free running circadian rhythm and delayed sleep phase syndrome |
Yellow only applies to Circadin m/r tablets or Adaflex immediate release or oral solution 5mg/5ml. Other formulations are secondary care only. |
| MELATONIN (doses of 10mg daily or less) | Yellow | Sleep disorders children (see comments) continued in adults if proven efficacy in childhood |
Yellow only applies to the products stated in the LMSG guidance. Other formulations are secondary care only.
|
| RANIBIZUMAB | Red | Age-related macular degeneration, diabetic macular oedema, retinal vein occlusion | |
| SOMATROGON (Ngenla®) (NEW) | Grey | Treatment of children and adolescents from 3 years of age with growth disturbance due to insufficient secretion of growth hormone. |
Other Updates on this Website
Recent documents from LLR APC and TAS
SCA: Dantrolene(391 KB)
From 1st September 2022 Version 1
Date added: 1st Aug 2022
Antipsychotic prescribing guide for Primary Care(582 KB) - Guidelines
Implementation date 1st September 2022 Version 1
Date added: 29th Jul 2022
Hydrocortisone Sodium Phosphate Shortage(326 KB) - Guidelines
July 2022
Date added: 27th Jul 2022
Interim Inclisiran Pathway(779 KB) - Guidelines
Version 1 Uploaded July 22
Date added: 26th Jul 2022
LLRAPC Newsletter- July 22(568 KB) - LMSG/LLR APC newsletters
Date added: 21st Jul 2022
LLR Acne Algorithm(174 KB) - Guidelines
Version 3 Uploaded July 2022
Date added: 6th Aug 2020
Typical Antipsychotics shared care request form(260 KB) - Guidelines
In place until 1st September 2022
Date added: 10th Jul 2020
Atypical antipsychotics SCA request form(256 KB) - Shared care agreement
In place until 1st September 2022
Date added: 10th Jul 2020
Melatonin Guidelines for Children(948 KB) - Guidelines
Version 3.4 uploaded July 2022
Date added: 14th Aug 2018
SCA: Antipsychotics (atypical)(619 KB) - Shared care agreement
Version 4.2 uploaded April 2021. In place until 1st September 2022
Date added: 18th Dec 2017
Gastroenterology Biologic Treatments(585 KB) - Guidelines
Version 1.2 Uploaded July 22
Date added: 28th Nov 2017
LLRAPC STOMA Appliances and accessories Formulary and Prescribing Guidance(938 KB) - Guidelines
Version 2 Uploaded July 22
Date added: 14th Nov 2017
Guidelines for the Management of Catheterised Patients in the Community(186 KB) - Guidelines
Revised May 2022. Approved July 2022
Date added: 19th Apr 2017
Atypical Antipsychotics in Personality Disorder Shared Care Agreement(588 KB) - Shared care agreement
Version 2.2 Uploaded April 2021. In place until 1st September 2022
Date added: 25th Oct 2016
Atypical Antipsychotics in Personality Disorder Shared Care Request Form - Shared care agreement
In place until 1st September 2022
Date added: 25th Oct 2016
SCA: Typical Depot Antipsychotics(686 KB) - Shared care agreement
Version 2.0 Uploaded March 21 In place until 1st September 2022
Date added: 20th Aug 2015
Neuropathic Pain(872 KB) - Guidelines
Version 3 Uploaded July 2022
Date added: 28th May 2015
About the Leicester, Leicestershire and Rutland Area Prescribing Committee
In common with other local health communities, the Leicester, Leicestershire and Rutland Area Prescribing Committee (LLR APC) acknowledges the benefits of having a Leicestershire Health Community-wide strategy for the prescribing of specialist medicines and the managed entry of new drugs and related technologies.
Leicestershire Health Community comprises the three Clinical Commissioning Groups, University Hospitals of Leicester (UHL) NHS Trust and Leicestershire Partnership NHS Trust (LPT), amongst which there is a total consensus on the need for this strategy, and the LLR APC has been in place since 2005. Learn more